Evidence map›Paper›PMID 41904188›Full record

ArticleScientific reports2026

Analysis of the correlation between combined multiple cytokine detection and colorectal cancer.

Yihua Hui, Min Chu, Haina Wang, Laifeng Ren, Jinyu Wu, Xiaoyang Niu, Li Zhang, Wen Su

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yihua HuiDepartment of Gastroenterology, Taiyuan Central Hospital, Taiyuan, Shanxi, China.
Min ChuDepartment of Gastroenterology, Taiyuan Central Hospital, Taiyuan, Shanxi, China.
Haina WangShanxi Cancer Hospital, Taiyuan, Shanxi, China.
Laifeng RenShanxi Cancer Hospital, Taiyuan, Shanxi, China.
Jinyu WuDepartment of Occupational Hygiene, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi, China.
Xiaoyang NiuThe Ninth Clinical Medical College of Shanxi Medical University, Taiyuan, Shanxi, China.
Li ZhangDepartment of Gastroenterology, Taiyuan Central Hospital, Taiyuan, Shanxi, China. zhuangzhuang0622@163.com.
Wen SuShanxi Cancer Hospital, Taiyuan, Shanxi, China. suwen30@yahoo.com.

Funding

Health Commission of Shanxi Province YDZJSX2022A071Taiyuan Science and Technology Bureau 202207
6 · The paper itself

Abstract

The study attempted to investigate the clinical value of serum cytokine levels in diagnosing colorectal cancer. Peripheral blood samples were obtained from 56 patients with colorectal cancer (colorectal cancer group) and 25 healthy subjects (control group) diagnosed in the Pathology Department at Shanxi Cancer Hospital between April 2020 and November 2020. The levels of 14 serum cytokines (interleukin (IL)-1β, L-17 A, IL-10, IL-4, IL-5, IL-6, IL-8, IL-22, IL-33, IL-18, IL-2RA, tumor necrosis factor (TNF)-α, TNF-β, and interferon (IFN)-γ) were analyzed using AimPlex flow cytometry high-throughput multi-factor detection technology. IL-2RA and IL-6 levels were significantly higher in the serum of patients with colorectal cancer than in the control group (P < 0.01), and the difference was of high statistical significance. IFN-γ, IL-8, and IL-5 levels were generally higher in the colorectal cancer group than in the control group (P < 0.05), and this difference exhibited statistical significance. The logistic regression model revealed that the colorectal cancer risk increased by 4.66 times for each increase in IL-6 (pg/mL) (P < 0.01), and by 3.01 times for each increase in IFN-γ (pg/mL) (P < 0.05). The Bayesian Kernel Machine Regression model indicated that the colorectal cancer risk increased by 0.95 times when all cytokines were at 75% compared to when at 50%. Furthermore, when the remaining cytokines were exposed at P50, the single factor exposure model showed that the levels of IL-6, IFN-γ, and TNF-β increased from P25 to P75. In contrast, the risk of colorectal cancer associated with these cytokines increased by 0.29 times, 0.248 times, and 0.4919 times. Meanwhile, a positive association was observed between the mixed effects of the 14 cytokines and the occurrence of colorectal cancer. This study's multi-method analysis demonstrated that colorectal cancer patients had significantly higher serum levels of IL-2RA and IL-6 (P < 0.01) and elevated IFN-γ, IL-8, and IL-5 levels (P < 0.05). Multivariate logistic regression showed that IL-6 (P < 0.01) and IFN-γ (P < 0.05) were strongly associated with disease risk (1-unit Ln increase raised the risk by 4.66- and 4.01-fold, respectively). RCS confirmed that IL-6 (with/without Ln transformation) and Ln-transformed IL-10 correlated positively with incidence (all P < 0.05). BKMR indicated the 14-cytokine mixed exposure at the 75th vs. the 50th percentile increased risk by 0.95. The mixed effect of the 14 cytokines detected using the mixed detection method positively correlated with the occurrence of colorectal cancer. These findings provide novel diagnostic insight for colorectal cancer.

Indexed as

Biomarkers, TumorColorectal NeoplasmsCytokinesAdultAgedCase-Control StudiesFemaleHumansMaleMiddle AgedBiomarkers, TumorCytokinesColorectal cancerCytokinesHealthy control groupInterferon-γInterleukin-6

Identifiers

PMID41904188
PMCPMC13039449

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.